Cargando…
Never tear us a-PARP: Dealing with DNA lesions during mitosis
Tumors defective in homologous recombination (HR) are highly sensitive to poly ADP-ribose polymerase (PARP) inhibition, however the cell biological mechanisms underlying this synthetic lethality remain elusive. We recently identified that PARP inhibitor-induced DNA lesions persist until mitosis, sub...
Autores principales: | Schoonen, Pepijn M., van Vugt, Marcel A.T.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791853/ https://www.ncbi.nlm.nih.gov/pubmed/29404385 http://dx.doi.org/10.1080/23723556.2017.1382670 |
Ejemplares similares
-
Processing DNA lesions during mitosis to prevent genomic instability
por: Audrey, Anastasia, et al.
Publicado: (2022) -
Beyond DNA repair: the novel immunological potential of PARP inhibitors
por: Chabanon, Roman M., et al.
Publicado: (2019) -
The complexity of life and death decisions in mitosis
por: Diaz-Martinez, Laura A, et al.
Publicado: (2014) -
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
por: Schoonen, Pepijn M., et al.
Publicado: (2017) -
The mitosis-differentiation checkpoint, another guardian of the epidermal genome
por: Gandarillas, Alberto, et al.
Publicado: (2015)